Medicine

Many blame the agency's earlier guidance for suffering and even suicide risk among chronic pain patients. Critics say the updated advice may not fix the problem.

Now, more than two years into the pandemic, some parts of the U.S. are seeing an uptick in cases driven by the BA.2 subvariant.

In a 2-1 ruling Thursday, a panel of the 5th Circuit Court of Appeals in New Orleans reversed a lower court and ordered dismissal of a lawsuit challenging the mandate.

Key questions include how often the vaccines should be updated against new viral strains and who should get them.

Researchers found that people who had COVID-19 were about 40% more likely to develop diabetes within a year after recovering, compared to participants in a control group.

The chamber voted on a bill that caps the price of insulin at $35 a month but fate for the legislation in the Senate is unclear.

The Food and Drug Administration has long warned against using the cow and horse dewormer to fight COVID-19, warning it can cause serious, adverse effects.

The BA.2 strain now accounts for more than half of all coronavirus infections nationwide, the CDC estimates. The variant doesn't appear to make people sicker.

U.S. regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna COVID-19 vaccine.

Testing sites have had to turn people away now that they can’t bill the federal government. Vaccinators are bracing for a similar fate.

Though findings are preliminary, many studies suggest that vaccinated people have good protection against the condition, although just how much is still up for debate.

Moderna said in the coming weeks it would ask regulators in the U.S. and Europe to authorize two small-dose shots for youngsters under 6.

The company warned of several tainted lots of Accuretic and two other versions of the drug due to the presence of a nitrosamine above the Acceptable Daily Intake level.

In Pennsylvania, a growing number of divorced parents are taking their COVID vaccine disputes to court.

The request Thursday is broader than rival pharmaceutical company Pfizer’s request earlier this week for the regulator to approve a booster shot for all seniors.